1Hazama Y,Matsuhisa M, Ohtoshi K. et al. Beneficial effects of nateglinide on insulin resistance in type 2 diabetes [ J ]. Diabetes Res Clin Pract ,2006,71 ( 3 ) : 251- 255. 被引量：1
2Taki H, Maki T, Iso T, et al. Postmarketing study of nateglinide in Japan: treatment of medication - naive patients with type 2 diabetes [ J ]. Adv Ther,2005,22 (6) : 621-635. 被引量：1
4Campbell IW, Nateglinide - current and future role in the treatment of patients with type 2 diabetes mellitus [ J ]. Int J Clin Praet ,2005,59 (10) : 1218-1228. 被引量：1
6Rosenstock J, Hassman DR, Madder RD, et al. Repaglinide versus nateglinide monotherapy : a randomized, multicenter study [ J ]. Diabetes Care, 2004,27 ( 6 ) : 1265- 1270. 被引量：1
二级参考文献11
1Kahn SE, Verchere CB, Andrikopulos S, et al. Reduced anaylin release is a characteristis of impaired glucose tolerance and type 2 diabetes in Japancese Americans[ J ]. Diabetes, 1998,47(4) : 640 — 645. 被引量：1
2Uchino H, Niwa M, Shimizu T, et al. Impairment of early insulin response after glucose load, rather than insulin resistance,is responsible for postprandial hyperglycemia seen in obese type 2 diabetes: assessment using nateglinide, a new insulin secretagogue[ J ]. Endocr J ,2000,47(5) : 639 — 641. 被引量：1
3Bruce DG, Chisholm DJ, Storlien LH, et al. Physilolgical importance of deficiency in early prandial insulin secretion in non - dependent diabetes [ J ]. Diabetes, 1998,37 (6) : 736 — 744. 被引量：1
4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients[ J ]. Diabetes, 1999, 48 ( 1 ) : 99 — 105. 被引量：1
5Hanefeld - M, Temelkova - Kurktschiev - T. Control of post - prandial hyperglycemia- an essential part of good diabetes treatment and prevention of cardiovascular complications [ J ].Nutr- Metab - Cardiovasc - Dis,2002,12(2) : 98 — 107. 被引量：1
6Bell - D - S. Importance of postprandial glucose control [ J ]. South - Med - J,2001,94(8) : 804 — 809. 被引量：1
7Odawara - M. Nateglinide and Mitiglinide[ J ]. Nippon - Rinsho, 2003 , 61 (7) : 1230 — 1237. 被引量：1
8Jyoti B,Kalbag,Jerry R,et al. Mealtime glucose regulation with mateglinide in healthy volunteers[ J ]. Diabetes care, 2001 ,24(1) : 73 — 77. 被引量：1
9Hr S, Wang S, Fanelli B, et al. Pancreatic β - cell KATP channel activity and membrane binding studies with nateglinide:a comparison with sulfonylureas and repaglinde[ J ]. J Pharmacol Exp Ther, 2000, 293 (2) : 444 — 452. 被引量：1
